TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/23 20:39 | 10/2/23 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bernards Rene | P7 | D | P.am | 24 | 2.41 | 0 | 10 | 67 | 25 | D | |||||||||||||||
10/4/23 18:10 | 10/2/23 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bernards Rene | P7 | D | P.m | 24 | 2.41 | 0 | 10 | 0 | D | ||||||||||||||||
12/16/22 19:30 | 12/15/22 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bernards Rene | P7 | D | P | 8 | 0.5100 | 0 | 15 | 11 | 150 | D | |||||||||||||||
12/13/22 11:44 | 12/12/22 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bernards Rene | P7 | D | P | 6 | 0.6100 | 0 | 10 | 8 | 135 | D | |||||||||||||||
11/15/22 19:44 | 11/14/22 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bernards Rene | P7 | D | P | 28 | 0.5300 | 0 | 53 | 72 | 125 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |